Wendy L. Yarno
CIK: 0001181186
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct302 shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
1.2K shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
2.4K shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
3.8K shares- - Jun 16, 2026IDYA
IDEAYA Biosciences, Inc.
Award(A)DirectStock Option (right to buy)
20K shares- - Jun 12, 2026TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct3K shares- - May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Unit
34.2K shares- - May 20, 2026INO
INOVIO PHARMACEUTICALS, INC.
Award(A)DirectCommon Stock Options
41.8K shares- - Jun 24, 2025IDYA
IDEAYA Biosciences, Inc.
Award(A)DirectStock Option (right to buy)
20K shares- - Jun 13, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectDeferred Restricted Stock Unit
67.5K shares- - Jun 13, 2025TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct3.4K shares- - Jun 12, 2025TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
4.5K shares- - Jun 12, 2025TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
3K shares- - May 21, 2025INO
INOVIO PHARMACEUTICALS, INC.
Exercise(M)Direct2.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 |  TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 302 | - | $0 | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 1,209 | - | - | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 2,417 | - | - | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 3,837 | - | - | Direct |
| Jun 16, 2026 |  IDYA IDEAYA Biosciences, Inc. | Award(A) Stock Option (right to buy) | 20,000 | - | - | Direct |
| Jun 12, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 2,954 | - | $0 | Direct |
| May 20, 2026 |  INO INOVIO PHARMACEUTICALS, INC. | Award(A) Restricted Stock Unit | 34,200 | - | - | Direct |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | Award(A) Common Stock Options | 41,800 | - | - | Direct |
| Jun 24, 2025 | IDYA IDEAYA Biosciences, Inc. | Award(A) Stock Option (right to buy) | 20,000 | - | - | Direct |
| Jun 13, 2025 |  IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Deferred Restricted Stock Unit | 67,546 | - | - | Direct |
| Jun 13, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 3,350 | - | - | Direct |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 4,540 | - | - | Direct |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 2,954 | - | - | Direct |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | Exercise(M) | 2,167 | - | - | Direct |
1-14 of 14 transactions
About YARNO WENDY L
YARNO WENDY L (SEC CIK 0001181186) files insider reports with the SEC as Director of Tarsus Pharmaceuticals, Inc. (TARS), Director of IDEAYA Biosciences, Inc. (IDYA) and Director of INOVIO PHARMACEUTICALS, INC. (INO). Signal8 also holds filings tied to 1 other company.
Signal8 holds 9 ownership filings by YARNO WENDY L, all Form 4s, filed between May 21, 2025 and Sep 17, 2026. Those filings report 14 transactions, from May 21, 2025 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on YARNO WENDY L's filings is in IRVINE, CA.
Recent filings by YARNO WENDY L
- Sep 15, 2026: Option exercise of TARS shares (Form 4, code M).
- Jun 25, 2026: Grants or awards of TARS derivative securities (3 lines, Form 4, code A).
- Jun 16, 2026: Grant or award of IDYA derivative securities (Form 4, code A).
- Jun 12, 2026: Option exercise of TARS shares (Form 4, code M).
- May 20, 2026: Grants or awards of INO derivative securities (2 lines, Form 4, code A).
Other insiders filing for Tarsus Pharmaceuticals, Inc. (TARS)
- PYOTT DAVID E I, Director
- LINK WILLIAM J PHD, Director
- Azamian Bobak R., President/CEO and Board Chair
- Lin Elizabeth Yeu, Chief Medical Officer
- Neervannan Seshadri, Chief Operating Officer
- Goodrich Katherine, Director